Bacteremia due to Lachnoanaerobaculum umeaense in a patient with acute myeloid leukemia during chemotherapy: A case report, and a review of the literature.
Julie BodinMaria-Pilar Gallego-HernanzChloé Plouzeau JayleAnthony MichaudLauranne BroutinJulie CremniterChristophe BurucoaMaxime PichonPublished in: Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy (2024)
The present case reports a bacteremia due to Lachnoanaerobaculum umeaense (a Gram-positive, filamentous, rod-shaped, anaerobic, spore-forming bacillus present in the human oral microbiota) in a patient treated for acute myeloid leukemia. After failed identification by MALDI-TOF, identification was done by sequencing of 16s rRNA. The patient was successfully treated with Amoxicillin-clavulanic acid and ciprofloxacin for seven days. Comparison of V1-V3 regions of the bacterial 16S rRNA gene gene with published sequences failed to classify the strain as pathogenic or non-pathogenic based on this phylogenetic classification alone. Although Lachnoanaerobaculum gingivalis are known to be associated with bacteremia in patients with acute myeloid leukemia, this clinical case of infection by L. umeaense argues for further studies that will lead to more efficient classification of the infection by these microorganisms.
Keyphrases
- acute myeloid leukemia
- case report
- gram negative
- mass spectrometry
- machine learning
- allogeneic hematopoietic stem cell transplantation
- deep learning
- endothelial cells
- copy number
- microbial community
- pseudomonas aeruginosa
- randomized controlled trial
- squamous cell carcinoma
- ms ms
- systematic review
- radiation therapy
- multidrug resistant
- bioinformatics analysis
- rectal cancer
- newly diagnosed
- cystic fibrosis
- induced pluripotent stem cells
- case control
- clinical evaluation